This content is from: Germany

First compulsory licence application in India

Indian generic drug maker Natco has filed a compulsory licence application for the patent covering German pharma company Bayer’s anti-cancer drug Nexavar

To access our in-house intelligence please request a trial here.

Read this article – and more – for a 30 day period.


Are you already an Managing IP subscriber? Login here


Instant access to all of our content. Membership Options | 30 Day Trial